Nucpaedia
Nucpaedia
Infection · Diabetic foot

Diabetic Foot Infection

Snapshot

In the diabetic foot the central question is whether osteomyelitis is present — and whether bony change reflects infection or Charcot neuro-osteoarthropathy. MRI is the primary test (sensitivity ≈93%) but its specificity is limited (≈75%) because Charcot and infection overlap. ⁹⁹ᵐTc-HMPAO-labelled-WBC imaging and FDG PET/CT offer the highest specificity (≈92%), making them valuable problem-solvers — especially with SPECT/CT or PET/CT to separate bone from soft-tissue infection.

Diabetic foot osteomyelitis usually spreads contiguously from a soft-tissue ulcer, so localising infection (bone vs soft tissue) matters as much as detecting it. Charcot neuro-osteoarthropathy is the key mimic. Labelled-WBC imaging with a marrow scan, or FDG PET/CT, helps distinguish infection from uncomplicated Charcot when MRI is equivocal.

MRI ≈93% / ≈75%Sensitive, less specific
HMPAO-WBC & FDG≈92% specificity
SPECT/CTBone vs soft tissue
Simulated dorsal images of a right foot comparing Charcot neuro-osteoarthropathy, with matching midfoot WBC and marrow activity and mild diffuse FDG uptake, against osteomyelitis of the first metatarsal head under a plantar ulcer, with focal WBC uptake, no marrow activity and focal intense FDG uptake.
Figure. Simulated images: labelled-leucocyte, ⁹⁹ᵐTc-colloid marrow and FDG PET appearances in the diabetic foot. Uncomplicated Charcot shows congruent WBC/marrow uptake and diffuse low-grade FDG uptake, whereas osteomyelitis beside an ulcer shows marrow-incongruent WBC uptake and focal intense FDG uptake; SPECT/CT or PET/CT is needed to place uptake in bone rather than soft tissue.

Clinical context & when to image

  • Confirming or excluding osteomyelitis under a foot ulcer when MRI is equivocal, contraindicated or degraded by prior surgery/hardware.
  • Distinguishing osteomyelitis from Charcot neuro-osteoarthropathy.
  • Localising infection to bone versus soft tissue before debridement or surgery.
  • Assessing treatment response in selected cases (evidence limited).

Imaging strategy

  • MRI is the primary imaging test for its high sensitivity and anatomical detail.
  • ⁹⁹ᵐTc-HMPAO-labelled-WBC imaging, ideally with a ⁹⁹ᵐTc-sulfur-colloid marrow scan, adds specificity.
  • FDG PET/CT offers comparable sensitivity and high specificity; its ability to separate osteomyelitis from active Charcot is not yet established (insufficient evidence in EANM/SNMMI v2.0).
  • Three-phase bone scan is sensitive but non-specific in the neuropathic foot.
  • SPECT/CT or PET/CT localisation (bone vs soft tissue) is essential.

Protocol

  • Labelled-WBC with paired ⁹⁹ᵐTc-colloid marrow imaging where Charcot or marrow-containing bone is in question (mandatory for Charcot per EANM).
  • FDG PET/CT: standard whole-body/lower-limb acquisition with glycaemic control.
  • SPECT/CT or PET/CT over the foot for precise localisation.
  • Correlate with recent MRI and the site of any ulcer.

How to read it

  • Labelled WBC: focal marrow-incongruent uptake at bone favours osteomyelitis; uptake confined to soft tissue indicates soft-tissue infection.
  • Charcot without infection tends to show congruent WBC/marrow uptake and, on FDG, more diffuse mild uptake.
  • FDG: focal intense bone uptake favours osteomyelitis.
  • Always localise with SPECT/CT before attributing uptake to bone.

Diagnostic performance

A meta-analysis of diabetic-foot osteomyelitis reported the following pooled performance; ⁹⁹ᵐTc-HMPAO-labelled WBC and FDG PET/CT gave the highest specificity while sensitivity was comparable across techniques.

ModalitySensitivitySpecificity
MRI≈93%
≈75%
WBC — ¹¹¹In-oxine≈92%
≈75%
WBC — ⁹⁹ᵐTc-HMPAO≈91%
≈92%
FDG PET/CT≈89%
≈92%

Osteomyelitis versus Charcot

  • Charcot neuro-osteoarthropathy is the classic mimic of pedal osteomyelitis and often coexists with ulceration.
  • Infection favours focal, marrow-incongruent WBC uptake and focal intense FDG uptake, typically adjacent to an ulcer.
  • Uncomplicated Charcot tends to show congruent WBC/marrow uptake and diffuse, lower-grade FDG uptake at joints.
  • SPECT/CT and correlation with ulcer location are decisive.

Pitfalls

  • MRI specificity is limited because Charcot and infection overlap.
  • Soft-tissue infection (cellulitis, ulcer) can be mistaken for bone infection without SPECT/CT localisation.
  • The neuropathic foot shows non-specific bone-scan uptake.
  • Hyperglycaemia can degrade FDG image quality.
Evidence & guidelines
  • Meta-analytic data: ⁹⁹ᵐTc-HMPAO WBC and FDG PET/CT offer the highest specificity for diabetic-foot osteomyelitis, with comparable sensitivity to MRI.
  • IWGDF/IDSA 2023 recommends MRI when osteomyelitis remains in doubt after clinical assessment, radiographs and laboratory tests, and suggests PET, leucocyte scintigraphy or SPECT as alternatives to MRI (conditional recommendation, low-quality evidence); ACR Appropriateness Criteria take a similar approach.
  • Technique choice depends on local availability, expertise and the Charcot question.
Practise with a case